Literature DB >> 32606531

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?

Arunmozhimaran Elavarasi1, Vinay Goyal2.   

Abstract

Entities:  

Year:  2020        PMID： 32606531      PMCID： PMC7313600          DOI： 10.4103/aian.AIAN_363_20

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN： 0972-2327            Impact factor:   1.383


× No keyword cloud information.
  11 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  Myasthenia gravis due to hydroxychloroquine.

Authors:  O Varan; H Kucuk; A Tufan
Journal:  Reumatismo       Date:  2015-12-30

3.  Persisting chloroquine-induced myasthenia?

Authors:  J De Bleecker; J De Reuck; J Quatacker; F Meire
Journal:  Acta Clin Belg       Date:  1991       Impact factor: 1.264

4.  [The myasthenic syndrome after chloroquine].

Authors:  A Klimek
Journal:  Neurol Neurochir Pol       Date:  1999 Jul-Aug       Impact factor: 1.621

5.  Chloroquine myopathy and myasthenia-like syndrome.

Authors:  A Sghirlanzoni; R Mantegazza; M Mora; D Pareyson; F Cornelio
Journal:  Muscle Nerve       Date:  1988-02       Impact factor: 3.217

6.  [Follow-up and immunologic findings in drug-induced myasthenia].

Authors:  W Brüggemann; H Herath; A Ferbert
Journal:  Med Klin (Munich)       Date:  1996-05-15

7.  [Myasthenia syndrome during chloroquine treatment (author's transl)].

Authors:  F Schumm; H Wiethölter; A Fateh-Moghadam
Journal:  Dtsch Med Wochenschr       Date:  1981-12-25       Impact factor: 0.628

Review 8.  Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction.

Authors:  W Robberecht; J Bednarik; P Bourgeois; J van Hees; H Carton
Journal:  Arch Neurol       Date:  1989-04

9.  No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.

Authors:  J M Molina; C Delaugerre; J Le Goff; B Mela-Lima; D Ponscarme; L Goldwirt; N de Castro
Journal:  Med Mal Infect       Date:  2020-03-30       Impact factor: 2.152

10.  COVID 19: Neuromuscular Manifestations.

Authors:  Rajesh Benny; Satish V Khadilkar
Journal:  Ann Indian Acad Neurol       Date:  2020-04-21       Impact factor: 1.383
View more
  1 in total

1.  Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System.

Authors:  Michele Fusaroli; Emanuel Raschi; Milo Gatti; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Front Pharmacol       Date:  2021-12-08       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.